The Dutch biotechnology company ProQR has just presented (March 2021) the first results of a clinical trial, named Stellar, with QR-421a, an antisense oligonucleotide designed to stop vision loss o...
The researchers conducted an in-depth study of resistance to temozolomide, the first-line treatment for glioblastoma, to which many patients cease to respond over time
The molecular profiling of tumors has opened the door to more effective therapies adapted to the condition of each patient. However, this approach has posed new challenges to medical teams, who are re...
Aglaris Ltd, the innovator in cell therapy manufacturing, has been awarded three prestigious grants totalling over €2million to advance its breakthrough technologies towards commercialisation.
While the success of autologous chimeric antigen receptors (CAR) T-cell medicines cannot be denied, with the recent approvals of Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel) pavin...
Robots allow rehabilitation therapies that are more precise and better adapted to the patients’ recovery status to be performed, according to a study by the UPV/EHU-University of the Basque Country